Bristol Myers Squibb Co SEC filings CELG-RI
Bristol Myers Squibb Co has 1,003 filings in SEC EDGAR's recent list, going back to Apr 2, 2019. Its latest annual report, Form ARS, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 144 | Notice of proposed sale | Nov 6, 2026 | — |
| 4 | Insider transaction | Nov 4, 2026 | Nov 3, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Nov 1, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Nov 1, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Nov 1, 2026 |
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 2, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 9, 2026 |
| 144 | Notice of proposed sale | Sep 9, 2026 | — |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Aug 26, 2026 | Aug 25, 2026 |
| 144 | Notice of proposed sale | Aug 25, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| 4 | Insider transaction | Aug 4, 2026 | Aug 1, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Aug 1, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 30, 2026 | Jul 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 11-K | Employee savings plan report | Jun 5, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 5, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 5, 2026 | Dec 31, 2025 |
| S-8 | Employee stock plan registration | May 8, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
May 8, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 1, 2026 |
| 10-Q | Quarterly report | Apr 30, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 30, 2026 | Apr 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| DEFA14A | Additional proxy material | Apr 17, 2026 | — |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 144 | Notice of proposed sale | Apr 1, 2026 | — |
| 15-12G | Deregistration | Mar 27, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| ARS | Annual report to shareholders | Mar 25, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 25, 2026 | — |
| DEF 14A | Proxy statement | Mar 25, 2026 | May 5, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 10-K | Annual report | Feb 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 5, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Nov 18, 2025 | Nov 17, 2025 |
| CERT | Nyse certification | Nov 12, 2025 | — |
| 8-A12B | Filing | Nov 10, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 10, 2025 | Oct 31, 2025 |
| 424B5 | Prospectus supplement | Nov 7, 2025 | — |
| FWP | Free writing prospectus | Nov 5, 2025 | — |
| 4 | Insider transaction | Nov 4, 2025 | Nov 3, 2025 |
| 4 | Insider transaction | Nov 4, 2025 | Nov 1, 2025 |
| 4 | Insider transaction | Nov 4, 2025 | Nov 1, 2025 |
| 4 | Insider transaction | Nov 4, 2025 | Nov 1, 2025 |
| 8-K |
Current report
Other events
|
Nov 3, 2025 | Nov 3, 2025 |
| 424B2 | Prospectus | Nov 3, 2025 | — |
| POSASR | Filing | Oct 31, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 31, 2025 | — |
| 10-Q | Quarterly report | Oct 30, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 30, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Oct 6, 2025 | Oct 2, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Sep 1, 2025 |
| 144 | Notice of proposed sale | Sep 2, 2025 | — |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 3 | Initial insider ownership | Aug 5, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 2, 2025 |
| 10-Q | Quarterly report | Jul 31, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 31, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2025 | Jul 21, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 3 | Initial insider ownership | Jun 16, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 11-K | Employee savings plan report | Jun 6, 2025 | Dec 31, 2024 |
| 11-K | Employee savings plan report | Jun 6, 2025 | Dec 31, 2024 |
| 11-K | Employee savings plan report | Jun 6, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 3, 2025 |
| 3 | Initial insider ownership | Jun 4, 2025 | Jun 1, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 3, 2025 |
| 25-NSE | Delisting notice | May 15, 2025 | — |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| SC TO-T/A | Filing | May 13, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 7, 2025 | May 6, 2025 |
| SC TO-T/A | Filing | May 6, 2025 | — |
| 4 | Insider transaction | May 5, 2025 | May 1, 2025 |
| SC TO-T/A | Filing | May 5, 2025 | — |
| 4 | Insider transaction | Apr 29, 2025 | Apr 25, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 25, 2025 | — |
| 10-Q | Quarterly report | Apr 24, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 24, 2025 | Apr 24, 2025 |
| SC TO-T/A | Filing | Apr 23, 2025 | — |
| SC TO-T/A | Sc-to-t/a | Apr 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| DEFA14A | Additional proxy material | Apr 15, 2025 | — |
| SC TO-T | Filing | Apr 14, 2025 | — |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Mar 26, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 26, 2025 | — |
| DEF 14A | Proxy statement | Mar 26, 2025 | Dec 31, 2024 |
| SC TO-C | Filing | Mar 13, 2025 | — |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 20, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 18, 2025 | Feb 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 10-K | Annual report | Feb 12, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 6, 2025 | Feb 6, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BMY (NYSE), CELG-RI (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Princeton, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 14272
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.